Tag Archives: appoint

AltoVita Appoints Gabriele Gallotti as Board Observer and Announces Financial Partnership with Novum Capital Partners

  • Corporate accommodation platform AltoVita strengthens Board of Directors with appointment of Gallotti, who has over 20 years experience in financial industry

London, UK; 17th May 2022: AltoVita, the multi award-winning company that powers the corporate accommodation sector through enterprise software layered with a human-centric approach, today announces the appointment of Novum Capital Partners’ CEO and Founder, Gabriele Gallotti, as Board Observer.

Gallotti joins the company’s Board of Directors alongside his role as Founder of Novum Capital Partners. Prior to founding the company in 2018, he gained a wealth of experience in the financial sector, including the role of Managing Director at JP Morgan, where he built a client portfolio of over US$4 billion across 30 families. His specialty is advising his clients on their full balance sheet including all aspects of wealth planning, portfolio management, and credit advice. Gabriele’s role at AltoVita will see him further strengthen AltoVita’s financial capital structure.

Gabriele’s appointment comes as Novum backed AltoVita in its recent investment round, and has also committed future investment into the corporate booking platform. AltoVita, co-founded by Vivi Cahyadi Himmel and Karolina Saviova, is building the largest corporate accommodation inventory in the sector and has recently announced expansion into 1,238 cities worldwide. Backing from Novum will help accelerate the growth of the company and scale up its business development, customer success, and technology capabilities, including new safety and ESG features set to be announced at its upcoming Smart, Safe, Sustainable Summit on May 12th.

Vivi Cahyadi Himmel, CEO and Co-Founder at AltoVita, commented: “Karolina and I are truly honoured to have Gabriele join AltoVita’s Board of Directors and Novum Capital Partners as our financial partner. We know that his depth of experience will help us to level up our offering as we set our sights on future expansion. Novum’s investment into AltoVita will go a long way to support our accelerated growth amid the business travel boom, as the global mobility sector initiates an outburst of talent moves.”

Gabriele Gallotti commented: “AltoVita captured us from the very first moment with its simplicity and sophistication. Yet, our decision to join their journey was not only based on numbers but also the energy of the founders, their passion, tenacity, vision and most importantly the great alignment with Novum’s values. I am both humbled and proud to join the Board to help Vivi and Karolina modernise and dominate the corporate accommodation sector. I am certain it will be a fantastic adventure.”

Evaluate appoints Matthew Wright as Chief Financial Officer

London, UK and Boston, MA – 11 May 2022 – Evaluate, a leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today announced that it has appointed Matthew Wright as Chief Financial Officer. Wright will work closely with both the Evaluate and Norstella executive and finance teams as the newly merged organisation combines as a $1.6 billion global pharma commercial intelligence provider.

Wright commented: “This is a really exciting time to join the business as it comes together to build a comprehensive data, insight and intelligence solution that will inform and support the industry across the entire drug lifecycle from pipeline to patient.

“I look forward to working with the leadership team to further extend our reach so that we can make an even greater contribution to those that are bringing new drugs to market and help patients gain access to life-saving therapies, faster,” he said.

Wright has over 15 years’ experience as a seasoned executive, providing financial analysis of performance, growth and acquisition opportunities and strategic decision support to senior leadership teams. He joins Evaluate from Informa Intelligence where he was most recently Finance Director for Pharma and Financial. He previously held similar roles at TNT Express and Ascential and brings complementary knowledge of high value B2B subscription business to Evaluate.

Lucy Ralph, CAO of Evaluate, added: “We have ambitious growth plans for the future as a newly merged business. We are determined to build on our success to date by offering an end-to-end view of the pharmaceutical market landscape and I’m confident that Matt will play a central role in helping us to grow as a business.”